1.Clinical study on trophoblastic disease.
Sun Woo KIM ; Hee Song CHUN ; Hyung Sun KIM ; Young Lee KIM ; Shin Keun PARK
Korean Journal of Obstetrics and Gynecology 1993;36(7):1058-1067
No abstract available.
Trophoblasts*
2.Cytolgic features of placental site trophoblastic tumor-a case report of cervico-vaginal smear-.
Hye Rim PARK ; Yong Woo LEE ; Young Euy PARK
Korean Journal of Cytopathology 1993;4(2):150-155
No abstract available.
Trophoblasts*
3.A case of placenta site trophoblastic tumor(PSTT).
Hyun Tai SHIN ; Seon Kyung LEE ; Chu Yup HUM ; Seung Bo KIM
Korean Journal of Obstetrics and Gynecology 1993;36(12):3976-3982
No abstract available.
Placenta*
;
Trophoblasts*
4.Treatment with EMA-CO regimen in the management of high risk gestational trophoblastic tumor.
Young Min CHOI ; Jin Wan PARK ; Do Yeong HWANG ; Soon Beom KANG ; Hyo Pyo LEE
Korean Journal of Obstetrics and Gynecology 1991;34(1):91-100
No abstract available.
Trophoblastic Neoplasms*
;
Trophoblasts*
5.A case of trophoblastic pulmonary embolization associated with hydatidiform mole.
Sang Jin KIM ; Byung Min LEE ; Dong Hee PARK ; Man Soo YOON ; Won Whe KIM
Korean Journal of Obstetrics and Gynecology 1993;36(9):3529-3534
No abstract available.
Female
;
Hydatidiform Mole*
;
Pregnancy
;
Trophoblasts*
6.Implication for early implantation failure in women with hydrosalpinx : Hydrosalpingeal fluid inhibits trophoblast cell proliferation in vitro culture system.
Jee Ae LEE ; Bum Chae CHOI ; Hye Gyung BYUN ; Jung Wook KIM ; Jung Ryul HAN ; Geun Jae YOO ; Kye Hyun KIM ; Mi Gyung KOONG ; Joseph A HILL
Korean Journal of Obstetrics and Gynecology 2000;43(8):1344-1348
No abstract available.
Cell Proliferation*
;
Female
;
Humans
;
Trophoblasts*
7.Changes in urinary pseudouridine excretion by patients with trophoblastic diseases during anticancer chemotherapy.
Korean Journal of Obstetrics and Gynecology 1991;34(1):101-115
No abstract available.
Drug Therapy*
;
Humans
;
Pseudouridine*
;
Trophoblasts*
8.Effects of gonadotropin-releasing hormone and gonadal steroids on various hormones secretion in trophoblast cells.
Yong Hun CHEE ; Jin Woo KIM ; Gu Taek HAN ; Jae Keun JUNG ; Dae Hoon KIM ; Sung Eun NAMKOONG ; Seung Jo KIM ; Hun Young LEE
Korean Journal of Obstetrics and Gynecology 1992;35(12):1768-1778
No abstract available.
Gonadotropin-Releasing Hormone*
;
Gonads*
;
Steroids*
;
Trophoblasts*
9.New clinical classification according to clinico-biochemical risk factors in the management of untreated persistent gestational trophoblastic tumor.
Jung Il CHA ; Kwang Duck KO ; Seok Nyun BAE ; Jae Kun JUNG ; Chang Yee KIM ; Seung Jo KIM ; Hun Young LEE
Korean Journal of Obstetrics and Gynecology 1991;34(6):828-837
No abstract available.
Classification*
;
Risk Factors*
;
Trophoblastic Neoplasms*
;
Trophoblasts*
10.Misinterpretation of Pregnancy Related Changes: Effect on the Postpartum Regression Rate of Abnormal Cervical Smears in Pregnancy.
Korean Journal of Cytopathology 2007;18(1):13-19
An aim of this study was to evaluate an effect of misinterpretation of pregnancy related cellular changes on the postpartum regression rate of abnormal cervical smears in pregnancy. A series of 265 cases with abnormal cervical smears in pregnancy were selected from a database of cervical smear results. The selected cases were classified as regression, persistence, and progression based on the results of postpartum cervical smears and histology. Of the selected cases, 162 cases were classified as regression and the postpartum regression rate was 61.1% (162/265). We reviewed abnormal cervical smears in pregnancy these cases. The primary cytologic diagnoses of these cases were ASCUS (118 cases), AGUS (2 cases), ASCUS/AGUS (1 case), LSIL (25 cases), LSIL R/O HSIL (2 cases), and HSIL (14 cases). With information of the pregnacy, we identified decidual cells in 24 cases, but cells identified by the Arias-Stella reaction and trophoblasts were not found. Sixteen cases out of 162 cases were reclassified as a pregnancy related change rather than an abnormal. Desidual cells were considered as ASCUS in 15 cases and as LSIL in one case. The revised postpartum regression rate was 55.5%(147/265) and was lower than the original. Consequently, misinterpretation of the pregnancy related cellular changes has an effect on a rise of the postpartum regression rate of the abnormal cervical smear in pregnancy. Pathologists may diagnose pregnancy related cellular changes as abnormal findings if they do not have information regarding the pregnancy. Therefore, clinical information of pregnancy and knowledge about the pregnancy related cellular changes are essential to prevent misinterpretation.
Diagnosis
;
Postpartum Period*
;
Pregnancy*
;
Trophoblasts
;
Vaginal Smears*
Result Analysis
Print
Save
E-mail